文献速递肺结节与肺癌

瑞典全国队列研究显示第二原发肺癌发病率持续上升

Increase in second primary lung cancers in a nation-wide cohort study from Sweden.
PubMed 文献 · Thorax · 2026-09-15

该研究基于瑞典1961至2021年全国癌症登记数据,共识别853例第二原发肺癌(SPLC)。SPLC发病率自1980年起几乎呈线性增长,女性相对风险高于男性,早发性女性腺癌患者相对风险最高可达约20倍,提示对特定高危患者可考虑CT筛查。

要点

  • SPLC发病率自1980年起几乎线性增长,男女及四种主要组织学类型均呈相似趋势。
  • SPLC总体相对风险为3.59,女性(4.16)高于男性(2.99),腺癌与鳞癌后相近。
  • 55岁前诊断者相对风险达6.68,女性腺癌后达9.95,早发性女性腺癌特定T分期后最高约20倍。

核心结论

  • SPLC虽仍罕见但数量快速增加,相对于第一原发肺癌的相对风险较高。
  • 早发性腺癌等特定高危患者可考虑在CT筛查可用时进行早期检测。

研究设计与样本

  • 基于瑞典全国癌症登记1961至2021年的队列研究,共识别853例SPLC。

主要发现

  • SPLC发病率自1980年起几乎线性增长,男女及四种主要组织学类型间大致相同。
  • SPLC组织学构成:腺癌63.9%、鳞状细胞癌19.4%、小细胞癌9.6%、大细胞癌9.1%。
  • 女性首次腺癌后10年SPLC累积概率为0.019,鳞癌后0.015,小细胞癌和大细胞癌后0.008。
  • 男性对应累积概率分别为腺癌0.013、鳞癌0.012、小细胞癌0.002、大细胞癌0.005。
  • SPLC相对风险总体3.59,女性4.16高于男性2.99;55岁前诊断者总体6.68,女性腺癌后9.95,男性6.77。

临床怎么用

  • 关注早发性腺癌等高风险人群,在CT筛查可用时考虑早期检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We describe the occurrence of second primary lung cancers (SPLCs) and their determinant in Sweden. METHODS: Nation-wide cancer registry from years 1961 to 2021 identified a total of 853 SPLCs. RESULTS: The incidence of SPLCs increased almost linearly from 1980 onwards, equally for women and men and approximately equally after the four main histological types. SPLC included adenocarcinoma 63.9%, squamous cell carcinoma (SCC) 19.4%, small cell carcinoma 9.6% and large cell carcinoma 9.1%. The female cumulative probability (CumP) of SPLC after first adenocarcinoma in 10 years reached 0.019, after SCC 0.015 and after small and large cell carcinoma 0.008. The respective CumP for men was 0.013, 0.012, 0.002 and 0.005. While adenocarcinoma was often followed by second adenocarcinoma, after first non-adenocarcinoma SPLCs presented in diverse histologies. Relative risk of SPLC compared with first lung cancer was overall 3.59, higher for women (4.16) than for men (2.99) and approximately equally high after adenocarcinoma and SCC. In patients diagnosed before age 55 years, the relative risk was 6.68 for all, but after female adenocarcinoma it was 9.95 compared with 6.77 for males. The highest relative risks, up to 20-fold, were found after early onset female adenocarcinoma diagnosed after defined T stages. CONCLUSIONS: Although SPLCs are still rare, their number is increasing rapidly and the relative risks compared with first lung cancer are substantial, qualifying selected groups of high-risk patients, such as patients with early onset adenocarcinoma for early detection by CT screening when/if such tests become available.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Zitricky F, Sundquist K, Sundquist J, et al. Increase in second primary lung cancers in a nation-wide cohort study from Sweden. Thorax. 2026. PMID: 41748422. doi:10.1136/thorax-2025-223426

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。